Alaska Oncology and Hematology ( Site 0121) — Anchorage, Alaska

Alaska Oncology and Hematology ( Site 0121) is a clinical research site located in Anchorage, Alaska, United States 99508.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Alaska Oncology and Hematology ( Site 0121) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alaska Oncology and Hematology ( Site 0121)?

Alaska Oncology and Hematology ( Site 0121) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alaska Oncology and Hematology ( Site 0121) conducted?

Alaska Oncology and Hematology ( Site 0121) has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma.

Is Alaska Oncology and Hematology ( Site 0121) accredited by Crixeo Health?

Alaska Oncology and Hematology ( Site 0121) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alaska Oncology and Hematology ( Site 0121)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.